DS
ETON icon

David Shaw’s Eton Pharmaceutcials ETON Stock Holding History

David Shaw’s Portfolio ETON Stock Details ETON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.82M Buy
+188,452
New +$5.53M ﹤0.01% 2163
2026
Q1 		– Sell
-15,331
Closed -$259K – 4675
2025
Q4 		$259K Buy
+15,331
New +$270K ﹤0.01% 4221
2021
Q1 		– Sell
-10,209
Closed -$83K – 4168
2020
Q4 		$83K Buy
+10,209
New +$78.8K ﹤0.01% 3830

Other funds holding ETON

OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $6.92B AUM 24.7% 1-Year Est. Return

David Shaw's ETON Position: Q2 2026 in Review

David Shaw opened a new position in Eton Pharmaceutcials (ETON) in Q2 2026: 188,452 shares worth $6.82M. The stake represents ﹤0.01% of the portfolio and ranks #2163 among its holdings. This is a return to the name: David Shaw previously reported a position in ETON as recently as Q4 2025.

David Shaw first reported a position in ETON in Q4 2020 and has held it in 3 quarters since. 165 funds tracked by Wall St. Rank hold ETON as of Q2 2026.

  • David Shaw held 188,452 shares of Eton Pharmaceutcials worth $6.82M as of Q2 2026.
  • Eton Pharmaceutcials was a new David Shaw position in Q2 2026.
  • Eton Pharmaceutcials made up ﹤0.01% of David Shaw's portfolio in Q2 2026, its #2163 holding.
  • David Shaw first reported a position in Eton Pharmaceutcials in Q4 2020 and has held it in 3 quarters since.
  • 165 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.